$CATX
Perspective Therapeutics Inc

2020 Q3 Form 10-Q Financial Statement

#000143774920023837 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $2.384M $2.315M
YoY Change 2.98% 48.21%
Cost Of Revenue $1.138M $1.079M
YoY Change 5.47% 3.95%
Gross Profit $1.246M $1.236M
YoY Change 0.81% 135.88%
Gross Profit Margin 52.27% 53.39%
Selling, General & Admin $1.648M $1.912M
YoY Change -13.81% 17.88%
% of Gross Profit 132.26% 154.69%
Research & Development $312.0K $233.0K
YoY Change 33.91% -44.52%
% of Gross Profit 25.04% 18.85%
Depreciation & Amortization $34.00K $38.00K
YoY Change -10.53% 18.75%
% of Gross Profit 2.73% 3.07%
Operating Expenses $1.960M $2.072M
YoY Change -5.41% 1.47%
Operating Profit -$714.0K -$836.0K
YoY Change -14.59% -44.93%
Interest Expense $1.000K $20.00K
YoY Change -95.0% 100.0%
% of Operating Profit
Other Income/Expense, Net $1.000K $20.00K
YoY Change -95.0% 100.0%
Pretax Income -$713.0K -$816.0K
YoY Change -12.62% -45.96%
Income Tax
% Of Pretax Income
Net Earnings -$713.0K -$816.0K
YoY Change -12.62% -45.89%
Net Earnings / Revenue -29.91% -35.25%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$10.35K -$12.11K
COMMON SHARES
Basic Shares Outstanding 68.90M 67.39M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.940M $4.575M
YoY Change -57.6% -50.22%
Cash & Equivalents $1.940M $4.575M
Short-Term Investments
Other Short-Term Assets $407.0K $209.0K
YoY Change 94.74% -59.81%
Inventory $641.0K $501.0K
Prepaid Expenses
Receivables $1.758M $1.521M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.746M $6.806M
YoY Change -30.27% -39.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.814M $1.669M
YoY Change 8.69% 19.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.0K $151.0K
YoY Change -15.23% -18.38%
Total Long-Term Assets $3.279M $3.318M
YoY Change -1.18% 59.83%
TOTAL ASSETS
Total Short-Term Assets $4.746M $6.806M
Total Long-Term Assets $3.279M $3.318M
Total Assets $8.025M $10.12M
YoY Change -20.73% -24.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $758.0K $984.0K
YoY Change -22.97% -15.9%
Accrued Expenses $764.0K $682.0K
YoY Change 12.02% 45.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.522M $1.666M
YoY Change -8.64% 1.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.408M $1.503M
YoY Change -6.32% 150.5%
Total Long-Term Liabilities $1.408M $1.503M
YoY Change -6.32% 150.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.522M $1.666M
Total Long-Term Liabilities $1.408M $1.503M
Total Liabilities $2.930M $3.169M
YoY Change -7.54% 41.79%
SHAREHOLDERS EQUITY
Retained Earnings -$88.65M -$85.31M
YoY Change 3.92% 5.51%
Common Stock $93.75M $92.26M
YoY Change 1.61% 0.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.095M $6.955M
YoY Change
Total Liabilities & Shareholders Equity $8.025M $10.12M
YoY Change -20.73% -24.13%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$713.0K -$816.0K
YoY Change -12.62% -45.89%
Depreciation, Depletion And Amortization $34.00K $38.00K
YoY Change -10.53% 18.75%
Cash From Operating Activities -$338.0K -$653.0K
YoY Change -48.24% -59.49%
INVESTING ACTIVITIES
Capital Expenditures $113.0K $98.00K
YoY Change 15.31% -14.04%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$113.0K -$98.00K
YoY Change 15.31% -98.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$338.0K -653.0K
Cash From Investing Activities -$113.0K -98.00K
Cash From Financing Activities
Net Change In Cash -$451.0K -751.0K
YoY Change -39.95% 84.52%
FREE CASH FLOW
Cash From Operating Activities -$338.0K -$653.0K
Capital Expenditures $113.0K $98.00K
Free Cash Flow -$451.0K -$751.0K
YoY Change -39.95% -56.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
110000
CY2020Q2 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
352000
CY2020Q3 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
108000
CY2020Q2 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
55000
CY2019Q3 isr Aro Discount Amount Interest Rate
AroDiscountAmountInterestRate
0.051
CY2019Q3 isr Aro Original Obligation Amount
AroOriginalObligationAmount
704000
CY2019Q3 isr Asset Retirement Obligation After Adjustment
AssetRetirementObligationAfterAdjustment
555000
CY2019Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
73000
CY2020Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
CY2019Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
73000
CY2020Q3 isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-189000
CY2019Q3 isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
105000
CY2020Q3 isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
56000
CY2019Q3 isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
-108000
CY2020Q3 isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
18000
CY2019Q3 isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
13000
CY2020Q3 isr Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
8000
CY2020Q3 isr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
8000
CY2015Q4 isr Purchase Agreement Period
PurchaseAgreementPeriod
P1Y
CY2020Q3 isr Restocking Fee Percentage
RestockingFeePercentage
0.5
CY2020Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
18000
CY2019Q3 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
3000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
758000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
654000
CY2020Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
91000
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
35000
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
222000
CY2020Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
204000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7552000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7517000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
93677000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
93592000
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10000
CY2019Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
11000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11672000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10760000
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
577000
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
621000
CY2020Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
585000
CY2019Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
555000
CY2020Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
8000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
4746000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
5507000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1940000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2392000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4575000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2122000
CY2019Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7000
CY2020Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
585000
CY2020Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
577000
CY2020Q3 us-gaap Assets
Assets
8025000
CY2020Q2 us-gaap Assets
Assets
8699000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4756000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2573000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5507000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2122000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4756000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-451000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-751000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68897779
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68897779
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68897779
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68897779
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
69000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
69000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1138000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1079000
CY2020Q3 us-gaap Depreciation
Depreciation
34000
CY2019Q3 us-gaap Depreciation
Depreciation
38000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
585000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y54D
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1067000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1097000
CY2020Q3 us-gaap Gross Profit
GrossProfit
1246000
CY2019Q3 us-gaap Gross Profit
GrossProfit
1236000
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
106000
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
301000
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-286000
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
367000
CY2020Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63000
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000
CY2020Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6000
CY2019Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18000
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-97000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23000
CY2020Q3 us-gaap Inventory Net
InventoryNet
641000
CY2020Q2 us-gaap Inventory Net
InventoryNet
645000
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
204000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
137000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
381000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
401000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
240000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
221000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1067000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
264000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
292000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
219000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
111000
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q3 us-gaap Liabilities
Liabilities
2930000
CY2020Q2 us-gaap Liabilities
Liabilities
2976000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1522000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1575000
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-338000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-653000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-713000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-816000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-716000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-819000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
1960000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2072000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-714000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-836000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
73000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
73000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
956000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
241000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
715000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
769000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
951000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1001000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y182D
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
100000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
581000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
815000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
85000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
91000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3732000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
94000
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
113000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
407000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
426000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9366000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9252000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1814000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1735000
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1758000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2044000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
312000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
233000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88651000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87938000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2384000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2315000
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1228000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.66
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
8250
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2500
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26250
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
274000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5533000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.62
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
164000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
274000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5533000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.62
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y226D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y324D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y226D
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5723000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
7680000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6955000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68898000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67388000

Files In Submission

Name View Source Status
0001437749-20-023837-index-headers.html Edgar Link pending
0001437749-20-023837-index.html Edgar Link pending
0001437749-20-023837.txt Edgar Link pending
0001437749-20-023837-xbrl.zip Edgar Link pending
ex_209774.htm Edgar Link pending
ex_209775.htm Edgar Link pending
ex_209776.htm Edgar Link pending
ex_209777.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20200930.xml Edgar Link completed
isr-20200930.xsd Edgar Link pending
isr-20200930_cal.xml Edgar Link unprocessable
isr-20200930_def.xml Edgar Link unprocessable
isr-20200930_lab.xml Edgar Link unprocessable
isr-20200930_pre.xml Edgar Link unprocessable
isr20200930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending